Form 4 for HRMY Harmony Biosciences Holdings, Inc.
Accepted 2025-12-09 00:00:00 ET · period of report 2025-12-05 · accession 0001677141-25-000008 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-12-09 | 2025-12-05 | HRMY | Kapadia Sandip | CFO | M - OptEx | $29.03 | +20.0K | 20.0K | New | +$580.6K |
| D | 2025-12-09 | 2025-12-05 | HRMY | Kapadia Sandip | CFO | S - Sale+OE | $39.54 | -20.0K | 0 | -100% | -$790.8K |
| D | 2025-12-09 | 2025-12-05 | HRMY | Kapadia Sandip | CFO | M - OptEx | $0.00 | -20.0K | 185.0K | -10% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-12-05 | M | A | 20,000 | $29.03 | 20,000 | D | — | — | |
| 2 | Common | Common Stock | 2025-12-05 | S | D | 20,000 | $39.54 | 0 | D | — | — | (F2) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.50 to $39.63. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 3 | Derivative | Stock Option | 2025-12-05 | M | D | 20,000 | $0.00 | 185,000 | D | $29.03 · — to 2031-03-29 | 20,000 Common Stock | (F3) The stock option shall vest with respect to 50% of the underlying shares on March 23, 2023 and with respect to the remaining shares, in twenty-four equal monthly installments beginning on April 23, 2023. |